Vertex Pharmaceuticals: A Diversification Play Poised to Join the Top 10 Global Healthcare Giants Nov 27, 2025 Life Science
Novartis Soars on New Drug Approval, But Its Long-Term Investment Case Runs Much Deeper Nov 26, 2025 Life Science
Novo Nordisk’s Stock Rebounds, Leveraging New-Generation Weight Loss Drugs and Price Reduction Strategy Nov 25, 2025 Life Science
Analyzing the Drivers Behind Johnson & Johnson’s Stock Price Increase This Month Nov 21, 2025 Life Science
Benefiting from Both Capacity Expansion and Drug Development, AstraZeneca’s Stock Performance Shines Nov 21, 2025 Life Science
With Capital and Policy Working in Tandem, Biotechnology ETFs Present a Strategic Investment Opportunity Nov 17, 2025 Life Science
Amgen’s Strong Q3 Performance and Multi-Faceted Strategy Drive Long-Term Value Nov 11, 2025 Life Science
GLP-1 Price Cut Storm: Lilly and Novo Nordisk Engage in Strategic “Volume-for-Value” Game Nov 10, 2025 Life Science
Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants Nov 6, 2025 Life Science
U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245 Nov 6, 2025 Life Science
Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month Nov 4, 2025 Life Science
Guardant Health Shares Soar 28% on Blowout Quarterly Results, Surging Test Volumes Oct 30, 2025 Life Science
Who Will Be the Next Winner in the Weight-Loss Drug Market? BioAge Labs Attracts Attention Oct 30, 2025 Life Science
